BDRX: Biodexa Pharmaceuticals plc - American Depositary Shares
今日BDRX汇率已更改-5.50%。当日,交易品种以低点5.33和高点5.64进行交易。
关注Biodexa Pharmaceuticals plc - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BDRX新闻
- Biodexa获得EMA批准进行FAP治疗三期临床试验
- Biodexa receives EMA approval for phase 3 FAP treatment trial
- Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading? - Biodexa Pharmaceuticals (NASDAQ:BDRX)
- Biodexa begins phase 3 trial of FAP treatment with $20M funding
- Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
- Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock?
- U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.74%
- Biodexa completes ADR ratio change to 1:100,000 ordinary shares
- Biodexa advances FAP treatment with phase 3 trial initiation
- How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
- Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
- Biodexa Pharmaceuticals to implement 1:10 ADR ratio change
- Biodexa files European clinical trial application for FAP treatment
- Results of Annual General Meeting
- Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
- Biodexa enrolls first patient in type 1 diabetes drug trial
- Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
- Biodexa Pharmaceuticals changes share nominal value
- Biodexa shareholders approve all resolutions at general meeting
- Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
- Shareholder Update
- Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Biodexa Pharmaceuticals (NASDAQ:BDRX)
- Biodexa secures additional $3M for cancer drug trial
- Biodexa Pharmaceuticals adjusts warrant exercise price
常见问题解答
BDRX股票今天的价格是多少?
Biodexa Pharmaceuticals plc - American Depositary Shares股票今天的定价为5.33。它在5.33 - 5.64范围内交易,昨天的收盘价为5.64,交易量达到21。BDRX的实时价格图表显示了这些更新。
Biodexa Pharmaceuticals plc - American Depositary Shares股票是否支付股息?
Biodexa Pharmaceuticals plc - American Depositary Shares目前的价值为5.33。股息政策取决于公司,而投资者也会关注-2.91%和USD。实时查看图表以跟踪BDRX走势。
如何购买BDRX股票?
您可以以5.33的当前价格购买Biodexa Pharmaceuticals plc - American Depositary Shares股票。订单通常设置在5.33或5.63附近,而21和-2.56%显示市场活动。立即关注BDRX的实时图表更新。
如何投资BDRX股票?
投资Biodexa Pharmaceuticals plc - American Depositary Shares需要考虑年度范围0.79 - 11.88和当前价格5.33。许多人在以5.33或5.63下订单之前,会比较-9.04%和。实时查看BDRX价格图表,了解每日变化。
Biodexa Pharmaceuticals Plc股票的最高价格是多少?
在过去一年中,Biodexa Pharmaceuticals Plc的最高价格是11.88。在0.79 - 11.88内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Biodexa Pharmaceuticals plc - American Depositary Shares的绩效。
Biodexa Pharmaceuticals Plc股票的最低价格是多少?
Biodexa Pharmaceuticals Plc(BDRX)的最低价格为0.79。将其与当前的5.33和0.79 - 11.88进行比较,可以发现潜在的长期切入点。观看BDRX在图表上的实时走势以获取更多详细信息。
BDRX股票是什么时候拆分的?
Biodexa Pharmaceuticals plc - American Depositary Shares历史上曾经历过股票拆分。这些变化在公司行动后的、5.64和-2.91%中可见。
- 前一天收盘价
- 5.64
- 开盘价
- 5.47
- 卖价
- 5.33
- 买价
- 5.63
- 最低价
- 5.33
- 最高价
- 5.64
- 交易量
- 21
- 日变化
- -5.50%
- 月变化
- -9.04%
- 6个月变化
- 398.13%
- 年变化
- -2.91%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 4.074%
- 预测值
- 前值
- 4.117%